Lab21 hires cfo

Susan Lowther joins Cambridge, UK-based firm

Lab21, a Cambridge, UK-based specialist in personalised medicine, has hired Susan Lowther as chief financial officer.

Lowther has spent more than 20 years in the pharmaceutical, biotech and healthcare industries and has held senior management positions at BioWisdom, RiboTargets, Lonza Biologics, Celltech and Monsanto.

Graham Mullis, Lab21 ceo, said: ‘Susan’s financial and life sciences industry expertise, particularly in the area of acquisitions, will be essential as we continue to develop the company.’

You may also like

Research & Development

Lab21 sells South Carolina laboratory operations

Will continue to focus on diagnostic content opportunities within the US market
Finance

Lab21 acquires Myconostica

Expands growing proprietary diagnostic portfolio
Manufacturing
Codis brings together formulation development, spray drying and commercial supply

Codis brings together formulation development, spray drying and commercial supply

Combining expertise across the UK and US, Codis supports customers from material characterisation and formulation development through scale-up, clinical studies and through to ongoing commercial manufacture and supply
Research & Development
Hanmi licenses UCN2 obesity drug candidate HM17321 to Genentech in $2.3bn deal

Hanmi licenses UCN2 obesity drug candidate HM17321 to Genentech in $2.3bn deal

Hanmi Pharm has granted Genentech global rights to develop and commercialise HM17321, an investigational UCN2 analogue designed to drive weight loss while preserving lean mass
Finance
Fulcrum Therapeutics merges with Slate Medicines in $245m-backed deal

Fulcrum Therapeutics merges with Slate Medicines in $245m-backed deal

The all-stock merger sees Fulcrum rebuild following its pociredir discontinuation, with the combined entity focusing on SLTE-1009 — a monoclonal antibody in development for migraine and headache disorders — funded into 2029
Manufacturing
Irish manufacturer brings EU GMP-certified dronabinol API to UK specials market

Irish manufacturer brings EU GMP-certified dronabinol API to UK specials market

Dunbar Pharmaceuticals partners with IPS Pharma to supply plant-derived dronabinol API for UK Specials-pathway cannabis medicines, following its earlier expansion into Germany
Training & Education
Why NSF QP Alumni continue learning, connecting and growing together

Why NSF QP Alumni continue learning, connecting and growing together

Discover why NSF QP Alumni return to continue learning, exchange experience and build trusted relationships that support their professional development and complex decisions across pharma
Subscribe now